Correlation Between Bluejay Diagnostics and CONMED

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bluejay Diagnostics and CONMED at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bluejay Diagnostics and CONMED into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bluejay Diagnostics and CONMED, you can compare the effects of market volatilities on Bluejay Diagnostics and CONMED and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bluejay Diagnostics with a short position of CONMED. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bluejay Diagnostics and CONMED.

Diversification Opportunities for Bluejay Diagnostics and CONMED

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Bluejay and CONMED is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Bluejay Diagnostics and CONMED in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CONMED and Bluejay Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bluejay Diagnostics are associated (or correlated) with CONMED. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CONMED has no effect on the direction of Bluejay Diagnostics i.e., Bluejay Diagnostics and CONMED go up and down completely randomly.

Pair Corralation between Bluejay Diagnostics and CONMED

Given the investment horizon of 90 days Bluejay Diagnostics is expected to generate 1.93 times less return on investment than CONMED. In addition to that, Bluejay Diagnostics is 7.83 times more volatile than CONMED. It trades about 0.01 of its total potential returns per unit of risk. CONMED is currently generating about 0.21 per unit of volatility. If you would invest  6,468  in CONMED on August 30, 2024 and sell it today you would earn a total of  848.00  from holding CONMED or generate 13.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Bluejay Diagnostics  vs.  CONMED

 Performance 
       Timeline  
Bluejay Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bluejay Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
CONMED 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in CONMED are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound primary indicators, CONMED is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Bluejay Diagnostics and CONMED Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bluejay Diagnostics and CONMED

The main advantage of trading using opposite Bluejay Diagnostics and CONMED positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bluejay Diagnostics position performs unexpectedly, CONMED can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CONMED will offset losses from the drop in CONMED's long position.
The idea behind Bluejay Diagnostics and CONMED pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities